Approval · Notice of Compliance 807 · 2002
RESTORIL: Notice of Compliance 807
Issued October 15, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 807
- Date
- October 15, 2002
- Company
- Oryx Pharmaceuticals Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hypnotic